Nova Leap Health Corp.
NVLPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,219 | $14,342 | $15,656 | $34,591 |
| - Cash | $1,403 | $895 | $1,273 | $1,733 |
| + Debt | $2,526 | $1,398 | $3,967 | $6,200 |
| Enterprise Value | $18,342 | $14,846 | $18,351 | $39,057 |
| Revenue | $25,761 | $26,179 | $28,205 | $21,279 |
| % Growth | -1.6% | -7.2% | 32.5% | – |
| Gross Profit | $9,887 | $9,768 | $9,975 | $7,211 |
| % Margin | 38.4% | 37.3% | 35.4% | 33.9% |
| EBITDA | $1,142 | -$336 | $367 | $3,736 |
| % Margin | 4.4% | -1.3% | 1.3% | 17.6% |
| Net Income | $1,378 | -$1,055 | -$836 | $1,761 |
| % Margin | 5.4% | -4% | -3% | 8.3% |
| EPS Diluted | 0.016 | -0.012 | -0.01 | 0.023 |
| % Growth | 229.5% | -18.4% | -145.8% | – |
| Operating Cash Flow | $1,388 | $2,155 | $1,021 | $2,180 |
| Capital Expenditures | -$24 | -$28 | -$71 | $0 |
| Free Cash Flow | $1,363 | $2,127 | $949 | $2,180 |